Humana Inc vs Intel Corp — how do they compare? Humana Inc trades at $437.2 (market cap $47.61B), while Intel Corp trades at $109.19 (market cap $597.96B). The key difference: Intel Corp is far larger — about 12.6× Humana Inc's market cap, and Intel Corp pays the higher dividend (2.24%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Intel Corp for 116 Days on average.
| HUM | INTC | |
|---|---|---|
Market Cap | $47.61B | $597.96B |
Volume | 1,827,332 | 82,330,296 |
Sector | Health | Technology |
52-Week High | $409.85 | $140.94 |
52-Week Low | $163.67 | $33.62 |
Typical Hold Time | 53 Days | 116 Days |
Enterprise Value | $54.97B | $618.77B |
Dividend Yield | 0.89% | 2.24% |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
Intel (INTC) trades at $107.08, down 4.82% today but maintains a bullish technical outlook with strong 2026 performance. The stock has surged over 220% year-to-date, driven by AI momentum and foundry growth. Recent earnings beats and High-NA chipmaking progress signal operational improvement, though negative profitability metrics and high valuations present challenges. Technical indicators show bullish momentum with key support at $109.
Intel's turnaround story shows promise with foundry revenue growth and government support, but faces execution risks against dominant competitors. The stock trades near analyst consensus target of $111.72, offering modest upside potential. Key risks include competitive pressures, margin challenges, and high debt levels that could limit near-term shareholder returns.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →Intel Corporation designs, manufactures, and sells computer components and related products. The Company major products include microprocessors, chipsets, embedded processors and microcontrollers, flash memory, graphic, network and communication, systems management software, conferencing, and digital imaging products.
Read more on INTC →